UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Delivery of Oncolytic Reovirus by Cell Carriers

Methods in molecular biology (Clifton, N.J.), 2020-01, Vol.2058, p.229

Ilett, Elizabeth J

2020

Volltextzugriff (PDF)

Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8⁺ T cell trafficking

Proceedings of the National Academy of Sciences - PNAS, 2018-02, Vol.115 (7), p.E1540-E1549

2018

Volltextzugriff (PDF)

Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

Clinical cancer research, 2009-07, Vol.15 (13), p.4374-4381

2009

Volltextzugriff (PDF)

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

Clinical cancer research, 2008-11, Vol.14 (22), p.7358-7366

2008

Volltextzugriff (PDF)

Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization

Clinical cancer research, 2011-05, Vol.17 (9), p.2767-2776

2011

Volltextzugriff (PDF)

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy

Cancer immunology research, 2018-10, Vol.6 (10), p.1161-1173

2018

Volltextzugriff (PDF)

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Nature communications, 2021-03, Vol.12 (1), p.1930-1930, Article 1930

2021

Volltextzugriff (PDF)

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001803

2021

Volltextzugriff (PDF)

Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming

Molecular cancer, 2011-02, Vol.10 (1), p.20-20, Article 20

2011

Volltextzugriff (PDF)

Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus

The Journal of immunology (1950), 2009-10, Vol.183 (7), p.4312-4321

2009

Volltextzugriff (PDF)

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment

Cancer immunology research, 2019-05, Vol.7 (5), p.828-840

2019

Volltextzugriff (PDF)

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review

Diagnostics (Basel), 2015-04, Vol.5 (2), p.119-176

2015

Volltextzugriff (PDF)

State anxiety and emotional face recognition in healthy volunteers

Royal Society open science, 2017-05, Vol.4 (5), p.160855-160855

2017

Volltextzugriff (PDF)

Cytokine-enhanced intravenous oncolytic virotherapy

The Lancet (British edition), 2014-02, Vol.383, p.S42-S42

2014

Volltextzugriff (PDF)

Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome

Cells (Basel, Switzerland), 2022-12, Vol.11 (24), p.4089

2022

Volltextzugriff (PDF)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion

Molecular therapy. Oncolytics, 2017-06, Vol.5 (C), p.75-86

2017

Volltextzugriff (PDF)

Past, Present and Future of Oncolytic Reovirus

Cancers, 2020-10, Vol.12 (11), p.3219

2020

Volltextzugriff (PDF)

JX-594, a targeted oncolytic poxvirus for the treatment of cancer

Current opinion in investigational drugs (London, England : 2000), 2009-12, Vol.10 (12), p.1372

2009

Volltextzugriff (PDF)

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Science translational medicine, 2018-01, Vol.10 (422)

2018

Volltextzugriff (PDF)

Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy

Gene therapy, 2017-01, Vol.24 (1), p.21-30

2017

Volltextzugriff (PDF)

Immunogenicity of self tumor associated proteins is enhanced through protein truncation

Molecular therapy. Oncolytics, 2016, Vol.3 (C), p.16030-16030, Article 16030

2016

Volltextzugriff (PDF)

Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus

Molecular therapy, 2014-10, Vol.22 (10), p.1851-1863

2014

Volltextzugriff (PDF)

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

Neuro-oncology (Charlottesville, Va.), 2016-04, Vol.18 (4), p.518-527

2016

Volltextzugriff (PDF)

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma

Nature biotechnology, 2012-04, Vol.30 (4), p.337-343

2012

Volltextzugriff (PDF)

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

Nature medicine, 2011-07, Vol.17 (7), p.854-859

2011

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(51)
Dissertationen
(1)

Sprache

Englisch
(51)
Dänisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(30)
Animals
(19)
Humans
(19)
Oncology
(15)
Cell Line, Tumor
(14)
Medicine, Research & Experimental
(13)
Mice
(13)
Mice, Inbred C57bl
(13)
Research & Experimental Medicine
(13)
Immunotherapy
(12)
Tumors
(12)
Melanoma
(11)
Immunology
(9)
Oncolytic Virotherapy
(9)
Viruses
(9)
Biotechnology & Applied Microbiology
(8)
Female
(8)
Melanoma, Experimental - Immunology
(8)
Melanoma, Experimental - Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Delivery of Oncolytic Reovirus by Cell Carriers

Anti–PD-1/anti–CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8⁺ T cell trafficking

Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization

Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche

Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming

Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus

Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review

State anxiety and emotional face recognition in healthy volunteers

Cytokine-enhanced intravenous oncolytic virotherapy

Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion

Past, Present and Future of Oncolytic Reovirus

JX-594, a targeted oncolytic poxvirus for the treatment of cancer

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy

Immunogenicity of self tumor associated proteins is enhanced through protein truncation

Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic Virus

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

Suchergebnisse filtern